This week, Zava, a telemedicine provider with over 3 million paid consultations to date, has announced a $32 million Series A investment ahead of its launch into statutory healthcare systems in Germany, France and the UK.
Zava’s mission is to build healthcare that is accessible, dependable and a fraction of today’s cost and patients seem to approve of its ability to provide the expert healthcare they need, both quickly and conveniently, with almost 100,000 people from around Europe accessing the service every month. Like other telemedicine companies, Zava enables patients to be connected with a doctor online within minutes, but unlike many others, Zava does not provide video consultations.
Zava's patient-doctor interactions are led, primarily, by written communication initiated by clinical questionnaires designed to save both doctor and patient time, whilst still upholding quality and safety. The questionnaires ask patients to describe their symptoms, upload relevant pictures, and answer symptom-specific questions. If necessary, a home testing kit will then be sent to the patient. A doctor reviews the information and provides advice and required treatment, which, depending on location, can be delivered straight to the patient’s home or collected from a local pharmacy within a few hours.
The questions reportedly match those asked by a physician in a face-to-face appointment and Zava says that by providing the patient with time to provide a considered written response, often the information provided can be more accurate and thorough, in turn enabling more personalized and effective care.
Zava claims that patients often struggle with the video consultations provided by other telemedicine services and the absence of the face-to-face element could serve to reduce some of the anxieties associated with seeing a doctor and may support more effective patient-to-clinician communication for those less comfortable discussing medical conditions that they might find embarrassing.
Currently, Zava’s business model is predominantly direct-to-consumer, although some customers are able to have fees reimbursed by their health insurer. With this latest raise, their sights are firmly set on exploring avenues that will enable them to integrate and synergize with local health systems like the UK's NHS to provide their service free at the point of care.
David Meinertz, Zava co-founder and CEO comments:
Now, more than ever, increasing numbers of telemedicine companies are entering the market, raising capital, growing, maturing and putting their own spin on delivering a service as they find their niche. And there seems to be room for a few different offerings. To give an idea of the size of the market; in 2018, Rock Health found "on-demand services" to be the number one value proposition of all companies across digital health, attracting $1.41 billion in funding across 50 deals. As people are looking for ever-personalized healthcare services, telemedicine providers like Zava are now offering real choice to patients of how and where they want to be diagnosed and treated.
Zava 的使命是构建可访问、可靠且仅占当前成本一小部分的医疗保健，而患者似乎认可其快速便捷地提供所需专业医疗保健的能力，欧洲各地的近10万人每月都能获得该服务。与其他远程医疗公司一样， Zava 允许患者在几分钟内在线与医生联系，但与其他许多公司不同， Zava 不提供视频咨询。
据报道，这些问题与医生在面对面预约中提出的问题相吻合。 Zava 说，通过给病人提供时间来提供经过深思熟虑的书面答复，通常所提供的信息可以更准确、更彻底，进而能够提供更加个性化和有效的护理。
目前， Zava 的商业模式主要是直接面向消费者的，尽管一些客户可以通过健康保险公司报销费用。随着这一最新进展，他们的目标是探索各种途径，使他们能够与英国 NHS 等地方卫生系统进行整合和协同，在护理点免费提供服务。
Zava 联合创始人兼首席执行官 David Meinertz 评论说：
现在，越来越多的远程医疗公司进入市场，筹集资金，发展，成熟，并把自己的优势放在提供服务上。而且似乎还有空间提供一些不同的产品。为了了解市场规模， RockHealth 在2018年发现“按需服务”是数字健康领域所有公司的首要价值主张，吸引了50笔交易的14.1亿美元资金。随着人们寻找日益个性化的医疗服务，像 Zava 这样的远程医疗服务提供商正在为患者提供如何诊断和治疗的真正选择。